TCL Archive Guideline Revisions or Outstanding Investigator Grant Still Controversial December 9, 1983
TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor January 6, 1989
TCL Archive Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network. March 26, 2004
